UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 933

Sortiert nach

Inflammatory Bowel Disease in the COVID-19 Pandemic: the Patients’ Perspective

Journal of Crohn's and colitis, 2020-06, Vol.14 (12), p.1702-1708

2020

Link zum Volltext

Verfügbarkeit prüfen

Vedolizumab induction therapy for inflammatory bowel disease in clinical practice – a nationwide consecutive German cohort study

Alimentary pharmacology & therapeutics, 2016-05, Vol.43 (10), p.1090-1102

2016

Link zum Volltext

Verfügbarkeit prüfen

Clinical characteristics and outcome of patients with enterococcal liver abscess

Scientific reports, 2021-11, Vol.11 (1), p.22265-22265, Article 22265

2021

Link zum Volltext

Verfügbarkeit prüfen

Vedolizumab provides clinical benefit over 1 year in patients with active inflammatory bowel disease – a prospective multicenter observational study

Alimentary pharmacology & therapeutics, 2016-12, Vol.44 (11-12), p.1199-1212

2016

Link zum Volltext

Verfügbarkeit prüfen

T Cell Response After SARS-CoV-2 Vaccination in Immunocompromised Patients with Inflammatory Bowel Disease

Journal of Crohn's and colitis, 2022-02, Vol.16 (2), p.251-258

2022

Link zum Volltext

Verfügbarkeit prüfen

Vedolizumab in the treatment of chronic, antibiotic‐dependent or refractory pouchitis

Alimentary pharmacology & therapeutics, 2018-03, Vol.47 (5), p.581-587

2018

Link zum Volltext

Verfügbarkeit prüfen

Consensus report: faecal microbiota transfer – clinical applications and procedures

Alimentary pharmacology & therapeutics, 2017-01, Vol.45 (2), p.222-239

2017

Link zum Volltext

Verfügbarkeit prüfen

Discrimination and classification of liver cancer cells and proliferation states by Raman spectroscopic imaging

Analyst (London), 2014-11, Vol.139 (22), p.636-643

2014

Link zum Volltext

Verfügbarkeit prüfen

Letter: predicting azathioprine‐associated pancreatitis in IBD—phenotype or genotype?

Alimentary pharmacology & therapeutics, 2018-04, Vol.47 (7), p.1042-1043

2018

Link zum Volltext

Verfügbarkeit prüfen

Effective use of ustekinumab for prepouch ileitis without improvement of concomitant pouchitis

Techniques in coloproctology, 2018-03, Vol.22 (3), p.251-252

2018

Link zum Volltext

Verfügbarkeit prüfen

Treatment of refractory ascites with an automated low‐flow ascites pump in patients with cirrhosis

Alimentary pharmacology & therapeutics, 2017-11, Vol.46 (10), p.981-991

2017

Link zum Volltext

Verfügbarkeit prüfen

Remission of refractory Crohn's disease by high-dose cyclophosphamide and autologous peripheral blood stem cell transplantation

Alimentary pharmacology & therapeutics, 2012-10, Vol.36 (8), p.725-735

2012

Link zum Volltext

Verfügbarkeit prüfen

Longterm course of neuropsychological symptoms and ME/CFS after SARS-CoV-2-infection: a prospective registry study

European archives of psychiatry and clinical neuroscience, 2023-08

2023

Link zum Volltext

Verfügbarkeit prüfen

The impact of specific cytokine directed treatment on severe COVID-19

Leukemia, 2021-12, Vol.35 (12), p.3613-3615

2021

Link zum Volltext

Verfügbarkeit prüfen

Regulation of the NLRP3 inflammasome in monocytes and macrophages from patients with decompensated cirrhosis by low-dose genotoxic stress

Journal of hepatology, 2017, Vol.66 (1), p.S585-S585

2017

Link zum Volltext

Verfügbarkeit prüfen

Clostridium difficile in the intensive care unit

Medizinische Klinik, Intensivmedizin und Notfallmedizin, 2020-03, Vol.115 (2), p.81

2020

Link zum Volltext

Verfügbarkeit prüfen

Ferric maltol therapy for iron deficiency anaemia in patients with inflammatory bowel disease: long‐term extension data from a Phase 3 study

Alimentary pharmacology & therapeutics, 2016-08, Vol.44 (3), p.259-270

2016

Link zum Volltext

Verfügbarkeit prüfen

The JAK1/2 inhibitor ruxolitinib in patients with COVID-19 triggered hyperinflammation: the RuxCoFlam trial

Leukemia, 2023-09, Vol.37 (9), p.1879-1886

2023

Link zum Volltext

Verfügbarkeit prüfen

NOD2 (CARD15) mutations in Crohn’s disease are associated with diminished mucosal α-defensin expression

Gut, 2004-11, Vol.53 (11), p.1658-1664

2004

Link zum Volltext

Verfügbarkeit prüfen

Emergence of spontaneous bacterial peritonitis due to enterococci - risk factors and outcome in a 12-year retrospective study

Alimentary pharmacology & therapeutics, 2012-05, Vol.35 (10), p.1199-1208

2012

Link zum Volltext

Verfügbarkeit prüfen

Confocal laser endomicroscopy reliably detects sepsis-related and treatment-associated changes in intestinal mucosal microcirculation

British journal of anaesthesia : BJA, 2013-12, Vol.111 (6), p.996-1003

2013

Link zum Volltext

Verfügbarkeit prüfen

Results of a S2k-Consensus Conference of the German Society of Gastroenterolgy, Digestive- and Metabolic Diseases (DGVS) in conjunction with the German Coeliac Society (DZG) regarding coeliac disease, wheat allergy and wheat sensitivity

Zeitschrift fur Gastroenterologie, 2014-07, Vol.52 (7), p.711

2014

Link zum Volltext

Verfügbarkeit prüfen

Long version on the S3 guidelines for axial spondyloarthritis including Bechterew's disease and early forms, Update 2019 : Evidence-based guidelines of the German Society for Rheumatology (DGRh) and participating medical scientific specialist societies and other organizations

Zeitschrift für Rheumatologie, 2019-12, Vol.78 (Suppl 1), p.3-64

2019

Link zum Volltext

Verfügbarkeit prüfen

Predictors of reduced health‐related quality of life in adults with coeliac disease

Alimentary pharmacology & therapeutics, 2007-03, Vol.25 (5), p.569-578

2007

Link zum Volltext

Verfügbarkeit prüfen

Soluble urokinase plasminogen activator receptor is compartmentally regulated in decompensated cirrhosis and indicates immune activation and short‐term mortality

Journal of internal medicine, 2013-07, Vol.274 (1), p.86-100

2013

Link zum Volltext

Verfügbarkeit prüfen

1 – 25 von 933

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(798)
Mit Volltextzugriff
(756)

Publikationsform

1 weiteren anzeigen...

Weniger anzeigen...

Sprache

2 weitere anzeigen...

Weniger anzeigen...

Erscheinungsjahr

n.n

Thema

Science & Technology
(528)
Life Sciences & Biomedicine
(462)
Humans
(447)
Female
(234)
Male
(207)
Gastroenterology & Hepatology
(204)
Adult
(159)
Biological And Medical Sciences
(153)
Medical Sciences
(138)
Middle Aged
(121)
Aged
(89)
Animals
(70)
Medicine
(68)
Gastroenterology
(65)
Medicine & Public Health
(63)
Inflammatory Bowel Disease
(60)
Physical Sciences
(59)
Gastroenterology. Liver. Pancreas. Abdomen
(50)
Internal Medicine
(50)
Ulcerative Colitis
(49)

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

5 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

Menü

Weitere Dienste

Einstellungen

Inflammatory Bowel Disease in the COVID-19 Pandemic: the Patients’ Perspective

Vedolizumab induction therapy for inflammatory bowel disease in clinical practice – a nationwide consecutive German cohort study

Clinical characteristics and outcome of patients with enterococcal liver abscess

Vedolizumab provides clinical benefit over 1 year in patients with active inflammatory bowel disease – a prospective multicenter observational study

T Cell Response After SARS-CoV-2 Vaccination in Immunocompromised Patients with Inflammatory Bowel Disease

Vedolizumab in the treatment of chronic, antibiotic‐dependent or refractory pouchitis

Consensus report: faecal microbiota transfer – clinical applications and procedures

Discrimination and classification of liver cancer cells and proliferation states by Raman spectroscopic imaging

Letter: predicting azathioprine‐associated pancreatitis in IBD—phenotype or genotype?

Effective use of ustekinumab for prepouch ileitis without improvement of concomitant pouchitis

Treatment of refractory ascites with an automated low‐flow ascites pump in patients with cirrhosis

Remission of refractory Crohn's disease by high-dose cyclophosphamide and autologous peripheral blood stem cell transplantation

Longterm course of neuropsychological symptoms and ME/CFS after SARS-CoV-2-infection: a prospective registry study

The impact of specific cytokine directed treatment on severe COVID-19

Regulation of the NLRP3 inflammasome in monocytes and macrophages from patients with decompensated cirrhosis by low-dose genotoxic stress

Clostridium difficile in the intensive care unit

Ferric maltol therapy for iron deficiency anaemia in patients with inflammatory bowel disease: long‐term extension data from a Phase 3 study

The JAK1/2 inhibitor ruxolitinib in patients with COVID-19 triggered hyperinflammation: the RuxCoFlam trial

NOD2 (CARD15) mutations in Crohn’s disease are associated with diminished mucosal α-defensin expression

Emergence of spontaneous bacterial peritonitis due to enterococci - risk factors and outcome in a 12-year retrospective study

Confocal laser endomicroscopy reliably detects sepsis-related and treatment-associated changes in intestinal mucosal microcirculation

Results of a S2k-Consensus Conference of the German Society of Gastroenterolgy, Digestive- and Metabolic Diseases (DGVS) in conjunction with the German Coeliac Society (DZG) regarding coeliac disease, wheat allergy and wheat sensitivity

Long version on the S3 guidelines for axial spondyloarthritis including Bechterew's disease and early forms, Update 2019 : Evidence-based guidelines of the German Society for Rheumatology (DGRh) and participating medical scientific specialist societies and other organizations

Predictors of reduced health‐related quality of life in adults with coeliac disease

Soluble urokinase plasminogen activator receptor is compartmentally regulated in decompensated cirrhosis and indicates immune activation and short‐term mortality

Suchergebnisse filtern